Infective endocarditis with neurological complications: Delaying cardiac surgery is associated with worse outcome.

Accident vasculaire cérébral Complication neurologique Endocardite Endocarditis Neurological complication Stroke Valve disease Valvulopathie

Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Historique:
received: 15 11 2020
revised: 23 01 2021
accepted: 28 01 2021
pubmed: 4 5 2021
medline: 26 10 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Infective endocarditis (IE) is associated with a high mortality rate, related in part to neurological complications. Studies suggest that valvular surgery should be performed early when indicated, but is often delayed by the presence of neurological complications. To assess the effect of delaying surgery in patients with IE and neurological complications and to identify factors predictive of death. In a prospective, single-centre study in a referral centre for IE, all patients with IE underwent systematic screening for neurological complications. The primary outcome was 6-month death. In patients presenting with neurological complications, the prognosis according to surgical status was analysed and a Cox regression model used to identify variables predictive of death. Between April 2014 and January 2018, 351 patients with a definite diagnosis of left-sided IE were included. Ninety-four patients (26.8%) presented with at least one neurological complication. Fifty-nine patients (17.7%) died during 6-month follow-up. Six-month mortality rates did not differ significantly between patients with and without neurological complications (P=0.60). Forty patients had a temporary surgical contraindication because of neurological complications. During the period of surgical contraindication, seven of these patients (17.5%) died, six (15.0%) presented a new embolic event, and 12 (30.0%) presented cardiac or septic deterioration. In multivariable analysis, predictive factors of death in patients presenting with neurological complications were temporary surgical contraindication (hazard ratio 7.36, 95% confidence interval 1.61-33.67; P=0.010) and presence of a mechanical prosthetic valve (hazard ratio 16.40, 95% confidence interval 2.22-121.17; P=0.006). Patients with a temporary surgical contraindication due to neurological complications had a higher risk of death and frequent major complications while waiting for surgery. When indicated, the decision to postpone surgery in the early phase should be weighed against the risk of infectious or cardiac deterioration.

Sections du résumé

BACKGROUND BACKGROUND
Infective endocarditis (IE) is associated with a high mortality rate, related in part to neurological complications. Studies suggest that valvular surgery should be performed early when indicated, but is often delayed by the presence of neurological complications.
AIM OBJECTIVE
To assess the effect of delaying surgery in patients with IE and neurological complications and to identify factors predictive of death.
METHODS METHODS
In a prospective, single-centre study in a referral centre for IE, all patients with IE underwent systematic screening for neurological complications. The primary outcome was 6-month death. In patients presenting with neurological complications, the prognosis according to surgical status was analysed and a Cox regression model used to identify variables predictive of death.
RESULTS RESULTS
Between April 2014 and January 2018, 351 patients with a definite diagnosis of left-sided IE were included. Ninety-four patients (26.8%) presented with at least one neurological complication. Fifty-nine patients (17.7%) died during 6-month follow-up. Six-month mortality rates did not differ significantly between patients with and without neurological complications (P=0.60). Forty patients had a temporary surgical contraindication because of neurological complications. During the period of surgical contraindication, seven of these patients (17.5%) died, six (15.0%) presented a new embolic event, and 12 (30.0%) presented cardiac or septic deterioration. In multivariable analysis, predictive factors of death in patients presenting with neurological complications were temporary surgical contraindication (hazard ratio 7.36, 95% confidence interval 1.61-33.67; P=0.010) and presence of a mechanical prosthetic valve (hazard ratio 16.40, 95% confidence interval 2.22-121.17; P=0.006).
CONCLUSIONS CONCLUSIONS
Patients with a temporary surgical contraindication due to neurological complications had a higher risk of death and frequent major complications while waiting for surgery. When indicated, the decision to postpone surgery in the early phase should be weighed against the risk of infectious or cardiac deterioration.

Identifiants

pubmed: 33935000
pii: S1875-2136(21)00068-1
doi: 10.1016/j.acvd.2021.01.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

527-536

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Florent Arregle (F)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Helene Martel (H)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Mary Philip (M)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Frederique Gouriet (F)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France.

Jean Paul Casalta (JP)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France.

Alberto Riberi (A)

Department of Cardiac Surgery, La Timone Hospital, 13005 Marseille, France.

Olivier Torras (O)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Anne-Claire Casalta (AC)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Laurence Camoin-Jau (L)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France; Department of Hematology, La Timone Hospital, 13005 Marseille, France.

Flora Lavagna (F)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Sebastien Renard (S)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Pierre Ambrosi (P)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Hubert Lepidi (H)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France.

Frederic Collart (F)

Department of Cardiac Surgery, La Timone Hospital, 13005 Marseille, France.

Sandrine Hubert (S)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France.

Michel Drancourt (M)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France.

Didier Raoult (D)

Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France.

Gilbert Habib (G)

AP-HM, La Timone Hospital, Cardiology Department, 13005 Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France. Electronic address: gilbert.habib3@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH